PB2021: QUALITY OF LIFE AND CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD): RESULTS OF A REAL-WORLD EVIDENCE STUDY

Detalles Bibliográficos
Autores principales: Ionova, T., Vinogradova, O., Kochkareva, Y., Ado, E., Kaplanov, K., Shirokova, M., Shelekhova, T., Levanov, A., Kopylova, A., Li, O., Mitina, T., Rukavitsyn, O., Simashova, P., Anchukova, L., Babich, E., Dasheeva, D., Demchenkova, M., Dubov, S., Esenina, T., Ivanova, L., Kravchuk, T., Rimashevskaya, E., Saraeva, N., Savinova, M., Volkova, S., Porfirieva, N., Nikitina, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429208/
http://dx.doi.org/10.1097/01.HS9.0000850916.45282.84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429208/
http://dx.doi.org/10.1097/01.HS9.0000850916.45282.84

Ejemplares similares